Akero Clinical Study Site

Dallas, Texas 75390

2 studies enrolling now · 6 studies all time

What they study most

MASH - Metabolic Dysfunction-Associated Steatohepatitis, MASH With Fibrosis, NAFLD/MASLD, NASH - Nonalcoholic Steatohepatitis, NASH With Fibrosis, NASH/MASH

Studies at this site

• A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis — Recruiting now
• A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH — Recruiting now
• A Study of Efruxifermin in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH) (Symmetry) — Completed
• A Study Evaluating Efruxifermin in Subjects With Non-invasively Diagnosed Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Nonalcoholic Fatty Liver Disease (NAFLD)/Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) — Running, not enrolling
• A Study of Efruxifermin in Non-Cirrhotic Subjects With Histologically Confirmed Nonalcoholic Steatohepatitis (NASH) — Completed
• A Study of Efruxifermin in Subjects With Histologically Confirmed Nonalcoholic Steatohepatitis (NASH) — Completed